NADMED offers a proprietary technology for measuring NADs and glutathiones through a novel nondestructive extraction and precise colorimetric quantification. This method efficiently extracts all metabolites from research samples of cells, liver, brain, muscle, and blood without damaging them. The technology employs a cyclic enzymatic reaction and colorimetric detection, making it compatible with standard laboratory equipment. Developed by Liliya Euro, NADMED’s approach includes the largest population dataset of NADs and has demonstrated high accuracy and repeatability, validated against mass spectrometry. NADMED stands as a leading solution in NAD measurement and metabolic research.